Articles > Health magazines > Medical magazines > Skin & Allergy News articles > August 2006

Article: New data back surgery for stage IV melanoma.(News)

Article from:
Skin & Allergy News
Article date:
August 1, 2006
Author:
Copyright

ATLANTA -- Stage IV melanoma patients lived much longer than expected after undergoing surgery for metastatic disease in a prospective registry trial presented at the annual meeting of the American Society of Clinical Oncology.

Dr. Jeffrey A. Sosman reported median overall survival had reached 21 months for 62 patients who were completely resected in the study by the Southwest Oncology Group (SWOG), a cooperative research organization.

This was three times longer than the 7-month median that SWOG had achieved in previous phase II studies enrolling a total of 412 stage IV melanoma patients.

Median progression-free survival was 6 months--much ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: CancerVax Announces Retrospective Analyses of Phase 2 Data on Its ...
Business Wire;  June 7, 2004 ;     700+ words ... ... overall survival of patients with Stage IV melanoma. Data ... over 510,000 patients in the United States ... manufacturing costs than patient-specific immunotherapies ... the treatment of patients with Stage III and Stage IV melanoma. About ...

Article: Data released on Canvaxin in treatment of patients with ...
Biotech Week;  July 7, 2004 ;     700+ words ... ... In an analysis of patients with Stage IV melanoma who did ... overall survival of 338 patients who received Canvaxin ... manufacturing costs than patient-specific immunotherapies ... the treatment of patients with Stage III and Stage IV melanoma. This article ...

Article: Published Data Indicate CancerVax's CANVAXIN Vaccine Increased ...
Business Wire;  January 3, 2003 ;     700+ words ... ... JWCI. Treatment for patients defined as "control ... for the treatment of patients with Stage III and Stage IV melanoma who have ... enrollment of new patients while CancerVax develops ... clinical hold on new patient enrollment is not ...

Article: A Stage IV Malignant Melanoma Drug That Increases ...
PR Newswire;  January 19, 2009 ;     700+ words ... ... drug for treating stage IV malignant melanoma ... would earn a higher patient share in the U ... Malignant Melanoma (Stage IV): Emerging Therapies ... Dacarbazine to Attain High Patient Share finds that ... Malignant Melanoma (Stage IV): Emerging Therapies ... Dacarbazine to ...

Article: AVAX Technologies' M-Vax Reported to Prolong Survival in Resected ...
PR Newswire;  November 13, 2000 ;     700+ words ... ... 400 melanoma patients who have received ... of these 37 stage IV melanoma patients, had visceral ... Vax to a patient population ... obtained in patients whose tumor ... stimulate the patient's own immune ... 2 trial in Stage IV melanoma ...

Article: Breast surgery in stage IV breast cancer: impact of ...
Advances in Breast Cancer;  September 1, 2008 ;     700+ words ...Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall ... definitive surgery in such patients and its impact on survival ... at data on 16,023 patients treated for stage IV breast cancer between ...

Article: Temozolomide with or without radiation therapy to the brain in ...
Journal of Drugs in Dermatology;  June 1, 2003 ;     700+ words ... ... therapy to the brain in treating patients who have stage IV melanoma with asymptomatic ... Whole Brain Radiotherapy in Patients With Stage IV Melanoma With Asymptomatic ... randomized, multicenter study. Patients are stratified according to ...

Article: Dendritic cell vaccine induces T-cell immunity in stage ...
Cancer Weekly;  November 4, 2003 ;     700+ words ... ... induction of T-cell immunity in patients with stage IV melanoma. According to a ... vaccinated 18 HLA A*0201(+) patients with stage IV melanoma with CD34 HPC ... induction of T-cell immunity in patients with stage IV melanoma. J Immunother ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives